Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen

PURPOSE: Recent data have shown that the expression levels of long noncoding RNAs (lncRNAs) are associated with tamoxifen sensitivity in estrogen receptor (ER)-positive breast cancer. Herein, we constructed an lncRNA-based model to predict disease outcomes of ER-positive breast cancer patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Gen, Chen, Xiaosong, Liang, Yue, Wang, Wei, Fang, Yan, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158153/
https://www.ncbi.nlm.nih.gov/pubmed/30275856
http://dx.doi.org/10.4048/jbc.2018.21.e39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158153/
https://www.ncbi.nlm.nih.gov/pubmed/30275856
http://dx.doi.org/10.4048/jbc.2018.21.e39

Ejemplares similares